Myelodysplastic subclones in chronic myeloid leukemia: implications for imatinib mesylate therapy

被引：8

作者：

Goldberg, SL ^{[1
]}

Madan, RA ^{[1
]}

Rowley, SD ^{[1
]}

Pecora, AL ^{[1
]}

Hsu, JW ^{[1
]}

Tantravahi, R ^{[1
]}

机构：

[1] Hackensack Univ, Med Ctr, Ctr Canc, Hackensack, NJ 07601 USA

来源：

BLOOD | 2003年 / 101卷 / 02期

关键词：

D O I：

10.1182/blood-2002-09-2769

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：781 / 781

页数：1

共 8 条

[1] CLONAL ORIGIN OF PHILADELPHIA-CHROMOSOME NEGATIVE CELLS WITH TRISOMY-8 APPEARING DURING THE COURSE OF ALPHA-INTERFERON THERAPY FOR PH POSITIVE CHRONIC MYELOCYTIC-LEUKEMIA [J].

ARIYAMA, T ;

INAZAWA, J ;

UEMURA, Y ;

KAKAZU, N ;

MAEKAWA, T ;

URASE, F ;

IRIMAJIRI, K ;

HORIUCHI, A ;

NAKAMURA, Y ;

ABE, T .

CANCER GENETICS AND CYTOGENETICS, 1995, 81 (01) :20-23

[2] Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience [J].

Braziel, RM ;

Launder, TM ;

Druker, BJ ;

Olson, SB ;

Magenis, RE ;

Mauro, MJ ;

Sawyers, CL ;

Paquette, RL ;

O'Dwyer, ME .

BLOOD, 2002, 100 (02) :435-441

[3] Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia [J].

Dewald, GW ;

Wyatt, WA ;

Juneau, AL ;

Carlson, RO ;

Zinsmeister, AR ;

Jalal, SM ;

Spurbeck, JL ;

Silver, RT .

BLOOD, 1998, 91 (09) :3357-3365

[4]

Druker B.J, 2002, P AN M AM SOC CLIN, V21, P1

[5] Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: Report of three cases [J].

Fayad, L ;

Kantarjian, H ;

OBrien, S ;

Seong, D ;

Albitar, M ;

Keating, M ;

Talpaz, M .

LEUKEMIA, 1997, 11 (05) :767-771

[6] Coexistence of independent myelodysplastic and Philadelphia chromosome positive clones in a patient treated with hydroxyurea [J].

Flamm, MJ ;

Murty, VVVS ;

Rao, PH ;

Nichols, GL .

LEUKEMIA RESEARCH, 2002, 26 (04) :417-420

[7] PROLONGED SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA AFTER CYTOGENETIC RESPONSE TO INTERFERON-ALPHA THERAPY [J].

KANTARJIAN, HM ;

SMITH, TL ;

OBRIEN, S ;

BERAN, M ;

PIERCE, S ;

TALPAZ, M ;

ROBERTSON, L ;

KOLLER, C ;

ESTEY, E ;

KEATING, MJ .

ANNALS OF INTERNAL MEDICINE, 1995, 122 (04) :254-261

[8] Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia [J].

Le Gouill, S ;

Talmant, P ;

Milpied, N ;

Daviet, A ;

Ancelot, M ;

Moreau, P ;

Harousseau, JL ;

Bataille, R ;

Avet-Loiseau, H .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) :1533-1538

← 1 →